Search

everythinglearnresearchcommunity

for

Search:↓

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Women with PCOS who have high male hormone levels often also have insulin resistance.

Feminizing hormone therapy increases hair counts and improves hair-related quality of life, while masculinizing therapy may reduce large terminal hairs.

The Hair Cell Analysis Toolbox automates and improves the analysis of cochlear hair cells using machine learning.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

Laser hair removal improves life quality short-term for women with PCOS-related hirsutism.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Reticulocyte hemoglobin content is the best indicator of iron deficiency in women with diffuse non-scarring hair loss.

Rathke’s cleft cysts can rarely cause Cushing disease, and surgery can improve symptoms.

Treating classic 21-hydroxylase deficiency requires precise glucocorticoid dosing and attention to individual patient needs, with new treatments showing promise.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Citrullus colocynthis fruit extract and its compound may help treat enlarged prostate.

Hairless protein can both repress and activate vitamin D receptor functions, affecting gene regulation.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Hypertrichosis involves excessive hair growth and needs careful diagnosis and treatment, considering its psychological effects.

RCS-01 is safe and may help rejuvenate aging skin.

CTP-543 is generally safe for treating alopecia areata.

A new plant-based treatment was effective for hair regrowth in women with a specific type of hair loss that didn't respond to usual treatments.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

Hair changes and a high occipital hairline may help diagnose Trichorhinophalangeal Syndrome.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

Regular endoscopic checks are crucial for Cronkhite-Canada syndrome patients to catch potential cancers early.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

Cyclohexyl salicylate promotes human hair growth and increases certain hair follicle stem cell progeny.

Reflectance confocal microscopy reliably identifies skin cancer features like horizontal skin tissue sections.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.